SMTL ID : 3lpb.1 (1 other biounit)

Crystal structure of Jak2 complexed with a potent 2,8-diaryl-quinoxaline inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x NVB: N-methyl-4-[3-(3,4,5-trimethoxyphenyl)quinoxalin-5-yl]benzenesulfonamide(Non-covalent)

NVB.1: 18 residues within 4Å: Chain A: L.18, G.19, K.20, G.21, V.26, A.43, V.74, M.92, E.93, Y.94, L.95, P.96, G.98, R.143, N.144, L.146, G.156, D.157 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.18, A:L.18, A:L.18, A:V.26, A:V.26, A:V.26, A:A.43, A:V.74, A:L.146 Hydrogen bonds: A:Y.94, A:L.95 Water bridges: A:K.20, A:D.102, A:R.143, A:N.144, A:N.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pissot-Soldermann, C. et al., Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-04-28

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence